KEMPHARM, INC.

Company

ZEVRA THERAPEUTICS, INC.

Filed

January 14, 2021

Accession Number

0000902664-21-000206

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →